Abstract
In 2009 the Endocrine Society’s clinical practice guidelines for care of transsexual persons were published. Since that time society and the medical community have experienced increased acceptance of gender transition in persons with gender dysphoria. The hormone treatment of transindividuals may render them infertile, and thus the guidelines recommend that individuals starting cross-sex hormones be counseled about their effects on fertility and possible fertility preservation options. In this chapter we examine the hormonal treatment for individuals with gender dysphoria, their effects on fertility, as well as fertility preservation options.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Intentionally grammatically incorrect to avoid using binary gender-based terminology.
Abbreviations
- BPA:
-
Bisphenol A
- DES:
-
Diethylstilbestrol
- DHEA:
-
Didehydroepiandrosterone
- GD:
-
Gender dysphoria
- GnRH:
-
Gonadotropin-releasing hormone
- PCBs:
-
Polychlorinated biphenyls
- PCOS:
-
Polycystic ovarian syndrome
- PESA:
-
Percutaneous sperm aspiration
- TESA:
-
Testicular sperm aspiration
- TESE:
-
Testicular sperm extraction
- WPATH:
-
World Professional Association for Transgender Health
References
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013.
Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, Endocrine Society, et al. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2009;94(9):3132–54.
World Professional Association for Transgender Health (WPATH). Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People. 7th Version. World Professional Association for Transgender Health. 2012.
de Delemarre-Van de Waal HA, Cohen-Kettenis PT. Clinical management of gender identity disorder in adolescents. Eur J Endocrinol. 2006;155 Suppl 1:S131–7.
Feldman J, Safer J. Hormone therapy in adults: suggested revisions to the sixth version of the standards of care. Int J Transgenderism. 2009;11(3):146–82.
Gooren L. Hormone treatment of the adult transsexual patient. Horm Res. 2005;64 Suppl 2:31–6.
Dumasia K, et al. Effect of estrogen receptor-subtype-specific ligands on fertility in adult male rats. J Endocrinol. 2015;225(3):169–80.
Gill-Sharma MK, et al. Antifertility effects of estradiol in adult male rats. J Endocrinol Invest. 2001;24(8):598–607.
Robaire B, Duron J, Hales BF. Effect of estradiol-filled polydimethylsiloxane subdermal implants in adult male rats on the reproductive system, fertility, and progeny outcome. Biol Reprod. 1987;37(2):327–34.
Sharpe RM, Skakkebaek NE. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet. 1993;341(8857):1392–5.
Fisch H, Hyun G, Golden R. The possible effects of environmental estrogen disrupters on reproductive health. Curr Urol Rep. 2000;1(4):253–61.
Skakkebaek NE, et al. Is human fecundity declining? Int J Androl. 2006;29(1):2–11.
Oliva A, Spira A, Multigner L. Contribution of environmental factors to the risk of male infertility. Hum Reprod. 2001;16(8):1768–76.
Rozati R, et al. Role of environmental estrogens in the deterioration of male factor fertility. Fertil Steril. 2002;78(6):1187–94.
Du Plessis SS, et al. The effect of obesity on sperm disorders and male infertility. Nat Rev Urol. 2010;7(3):153–61.
Pauli EM, et al. Diminished paternity and gonadal function with increasing obesity in men. Fertil Steril. 2008;90(2):346–51.
Palmer NO, et al. Impact of obesity on male fertility, sperm function and molecular composition. Spermatogenesis. 2012;2(4):253–63.
Pavlovich CP, et al. Evidence of a treatable endocrinopathy in infertile men. J Urol. 2001;165(3):837–41.
Hillier SG, Ross GT. Effects of exogenous testosterone on ovarian weight, follicular morphology and intraovarian progesterone concentration in estrogen-primed hypophysectomized immature female rats. Biol Reprod. 1979;20(2):261–8.
Goerlich VC, Dijkstra C, Groothuis TG. Effects of in vivo testosterone manipulation on ovarian morphology, follicular development, and follicle yolk testosterone in the homing pigeon. J Exp Zool A Ecol Genet Physiol. 2010;313(6):328–38.
Velez LM, et al. Effect of hyperandrogenism on ovarian function. Reproduction. 2015;149(6):577–85.
van der Spuy ZM, Dyer SJ. The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18(5):755–71.
Dumesic DA, Padmanabhan V, Abbott DH. Polycystic ovary syndrome and oocyte developmental competence. Obstet Gynecol Surv. 2008;63(1):39–48.
Amato MC, et al. Low estradiol-to-testosterone ratio is associated with oligo-anovulatory cycles and atherogenic lipidic pattern in women with polycystic ovary syndrome. Gynecol Endocrinol. 2011;27(8):579–86.
Light AD, et al. Transgender men who experienced pregnancy after female-to-male gender transitioning. Obstet Gynecol. 2014;124(6):1120–7.
Ellis SA, Wojnar DM, Pettinato M. Conception, pregnancy, and birth experiences of male and gender variant gestational parents: it’s how we could have a family. J Midwifery Womens Health. 2015;60(1):62–9.
Lawrence AA, Shaffer JD, Snow WR. Healthcare needs of transgendered patients. J Am Med Assoc. 1996;276:874.
American Academy of Child & Adolescent Psychiatry. Facts for Families: Children with Lesbian, Gay, Bisexual and Transgender Parents. Washington, DC; 2013.
The Ethics Committee of the American Society for Reproductive Medicine. Fertility Preservation and Reproduction in patients facing gonadotoxic therapies. Birmingham, AL; 2013.
Santelli JS, et al. Guidelines for adolescent health research. J Adolesc Health. 2003;33(5):396–409.
Fallat ME, Hutter J, American Academy of Pediatrics Committee on Bioethics, American Academy of Pediatrics Section on Hematology/Oncology, American Academy of Pediatrics Section on Surgery. Preservation of fertility in pediatric and adolescent patients with cancer. Pediatrics. 2008;121(5):e1461–9.
Bunge RG, Sherman JK. Fertilizing capacity of frozen human spermatozoa. Nature. 1953;172:767–8.
Wang JH, Muller CH, Lin K. Optimizing fertility preservation for pre- and postpubertal males with cancer. Semin Reprod Med. 2013;31:274–85.
Practice Committees of American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil Steril. 2013;99:37–43.
Wallace SA, Blough KL, Kondapalli LA. Fertility preservation in the transgender patient: expanding oncofertility care beyond cancer. Gynecol Endocrinol. 2014;30:1–4.
De Sutter P. Gender reassignment and assisted reproduction: present and future reproductive options for transsexual people. Hum Reprod. 2001;16(4):612–4.
Berookhim BM, Mulhall JP. Outcomes of operative sperm retrieval strategies for fertility preservation among males scheduled to undergo cancer treatment. Fertil Steril. 2014;101(3):805–11.
Reichman DE, Davis OK, Zaninovic N, Rosenwaks Z, Goldschlag DE. Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome. Fertil Steril. 2012;98(5):1225–8.
Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, Quinn G, Wallace WH, Oktay K, American Society of Clinical Oncology. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(19):2500–10.
Schover LR. Patient attitudes toward fertility preservation. Pediatr Blood Cancer. 2009;53(2):281–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Jarin, J., Johnson, E., Gomez-Lobo, V. (2017). Fertility Preservation in Patients with Gender Dysphoria. In: Woodruff, T., Gosiengfiao, Y. (eds) Pediatric and Adolescent Oncofertility. Springer, Cham. https://doi.org/10.1007/978-3-319-32973-4_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-32973-4_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32971-0
Online ISBN: 978-3-319-32973-4
eBook Packages: MedicineMedicine (R0)